Authors: Kuebler, JP King, GW Triozzi, P Moore, T Kraut, EH

Citation: Jp. Kuebler et al., Phase II study of pyrazoloacridine in metastatic renal cell carcinoma, INV NEW DR, 19(4), 2001, pp. 327-328

Authors: O'Donnell, MR Appelbaum, FR Baer, MR Carabasi, MH Coutre, SE Erba, HP Estey, E Glenn, MJ Kraut, EH Maslak, P Millenson, M Miller, CB Saba, HI Stone, R Tallman, MS

Citation: Mr. O'Donnell et al., NCCN Practice Guidelines for acute myelogenous leukemia, ONCOLOGY-NY, 14(11A), 2000, pp. 53-61

Authors: Kraut, EH Balcerzak, SP Young, D O'Rourke, MA Petrus, JJ Kuebler, JP Mayernik, DG

Citation: Eh. Kraut et al., A phase II study of 9-aminocamptothecin in patients with refractory breastcancer, CANCER INV, 18(1), 2000, pp. 28-31

Authors: Chauncey, TR Rankin, C Anderson, JE Chen, IM Kopecky, KJ Godwin, JE Kalaycio, ME Moore, DF Shurafa, MS Petersdorf, SH Kraut, EH Leith, CP Head, DR Luthardt, FW Willman, CL Appelbaum, FR

Citation: Tr. Chauncey et al., A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and theMDR modulator PSC 833: a Southwest Oncology Group study 9617, LEUK RES, 24(7), 2000, pp. 567-574

Authors: Kraut, EH

Citation: Eh. Kraut, Phase II trials of pentostatin (Nipent) in hairy cell leukemia, SEMIN ONCOL, 27(2), 2000, pp. 27-31

Authors: Karanes, C Kopecky, KJ Head, DR Grever, MR Hynes, HE Kraut, EH Vial, RH Lichtin, A Nand, S Samlowski, WE Appelbaum, FR

Citation: C. Karanes et al., A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia, LEUK RES, 23(9), 1999, pp. 787-794